202 related articles for article (PubMed ID: 12675696)
1. Arterial hypertension and ischaemic stroke.
Droste DW; Ritter MA; Dittrich R; Heidenreich S; Wichter T; Freund M; Ringelstein EB
Acta Neurol Scand; 2003 Apr; 107(4):241-51. PubMed ID: 12675696
[TBL] [Abstract][Full Text] [Related]
2. Hypertension and dyslipidemia treament in stroke.
Nussbaumerová B
Vnitr Lek; 2022; 68(3):172-177. PubMed ID: 36208947
[TBL] [Abstract][Full Text] [Related]
3. Drug therapy for the secondary prevention of stroke in hypertensive patients: current issues and options.
Lüders S
Drugs; 2007; 67(7):955-63. PubMed ID: 17488141
[TBL] [Abstract][Full Text] [Related]
4. [High blood pressure and coronary heart disease. Are there new therapeutic options?].
Motz W
Herz; 2004 May; 29(3):255-65. PubMed ID: 15167951
[TBL] [Abstract][Full Text] [Related]
5. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
[TBL] [Abstract][Full Text] [Related]
6. Optimal medical management of peripheral arterial disease.
Rice TW; Lumsden AB
Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological interventions for hypertension in children.
Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
[TBL] [Abstract][Full Text] [Related]
8. The use of secondary medical prevention after primary vascular reconstruction: studies on usage and effectiveness.
Høgh AL
Dan Med J; 2012 Sep; 59(9):B4514. PubMed ID: 22951205
[TBL] [Abstract][Full Text] [Related]
9. Cochrane in context: pharmacological interventions for hypertension in children.
Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS
Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306
[TBL] [Abstract][Full Text] [Related]
10. Effect of HMG-CoA reductase inhibitors on blood pressure in hypertensive patients treated with blood pressure-lowering agents: retrospective study using an anti-hypertensive drug database.
Hashimoto S; Urushihara H; Hinotsu S; Kosugi S; Kawakami K
Eur Rev Med Pharmacol Sci; 2012 Feb; 16(2):235-41. PubMed ID: 22428476
[TBL] [Abstract][Full Text] [Related]
11. Effects of blood-pressure-lowering treatment on outcome incidence in hypertension: 10 - Should blood pressure management differ in hypertensive patients with and without diabetes mellitus? Overview and meta-analyses of randomized trials.
Thomopoulos C; Parati G; Zanchetti A
J Hypertens; 2017 May; 35(5):922-944. PubMed ID: 28141660
[TBL] [Abstract][Full Text] [Related]
12. Impact of hypertension on stroke.
Dubow J; Fink ME
Curr Atheroscler Rep; 2011 Aug; 13(4):298-305. PubMed ID: 21626308
[TBL] [Abstract][Full Text] [Related]
13. The Hypertension Optimal Treatment study and the importance of lowering blood pressure.
Hansson L
J Hypertens Suppl; 1999 Feb; 17(1):S9-13. PubMed ID: 10340838
[TBL] [Abstract][Full Text] [Related]
14. [Angiotensin II type-1 receptor antagonists and diabetes mellitus].
Schnack C; Schernthaner G
Wien Med Wochenschr; 2001; 151(7-8):165-8. PubMed ID: 11450165
[TBL] [Abstract][Full Text] [Related]
15. A calcium channel or angiotensin converting enzyme inhibitor/angiotensin receptor blocker regime to reduced blood pressure variability in acute ischaemic stroke (CAARBS): A feasibility trial.
Davison WJ; Appiah K; Robinson TG; McGurgan IJ; Rothwell PM; Potter JF
J Neurol Sci; 2020 Jun; 413():116753. PubMed ID: 32151851
[TBL] [Abstract][Full Text] [Related]
16. Benefits of angiotensin converting enzyme inhibition and angiotensin II receptor antagonists in hypertension.
Conlin PR
J Med Liban; 2000; 48(6):382-6. PubMed ID: 11503531
[TBL] [Abstract][Full Text] [Related]
17. Effects of blood pressure lowering on outcome incidence in hypertension: 4. Effects of various classes of antihypertensive drugs--overview and meta-analyses.
Thomopoulos C; Parati G; Zanchetti A
J Hypertens; 2015 Feb; 33(2):195-211. PubMed ID: 25485720
[TBL] [Abstract][Full Text] [Related]
18. Renal protection in hypertensive patients: selection of antihypertensive therapy.
Wenzel RR
Drugs; 2005; 65 Suppl 2():29-39. PubMed ID: 16398060
[TBL] [Abstract][Full Text] [Related]
19. Are cholesterol-lowering medications and antihypertensive agents preventing stroke in ways other than by controlling the risk factor?
Ruland S; Gorelick PB
Curr Atheroscler Rep; 2003 Jan; 5(1):38-43. PubMed ID: 12562541
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-converting enzyme inhibitors reduce mortality compared to angiotensin receptor blockers: Systematic review and meta-analysis.
Salvador GL; Marmentini VM; Cosmo WR; Junior EL
Eur J Prev Cardiol; 2017 Dec; 24(18):1914-1924. PubMed ID: 28862020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
